

Publisher: John Wiley & Sons Inc
E-ISSN: 1556-7567|1527-8395|10|8-8
ISSN: 1527-8395
Source: THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol.1527-8395, Iss.10, 2015-10, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




FDA approves OxyContin for certain pediatric patients
ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 27, Iss. 36, 2015-09 ,pp. :


Impact of abuse‐deterrent OxyContin on prescription opioid utilization
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. :




Postmarketing Surveillance Study of OxyContin® Tablets for Relieving Moderate to Severe Cancer Pain
Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. :